Overview of the Intragastric Balloons Market
The intragastric balloons market is experiencing a surge in interest as a non-surgical option for weight loss. It is expected to grow from $32.2 million to $115.3 million by 2033, reflecting an impressive compound annual growth rate (CAGR) of 13.6%. This growth is largely driven by the rising rates of obesity and a growing preference for non-invasive procedures. Additionally, increased awareness and acceptance of this treatment among patients are contributing to the market's upward trend.
Key Drivers of Market Growth
Several key factors are propelling the growth of the intragastric balloons market:
Increasing Obesity Rates
Globally, obesity rates are on the rise, leading more individuals to seek effective weight management solutions. The public health crisis surrounding obesity is prompting patients to explore non-surgical alternatives like intragastric balloons.
Preference for Non-Surgical Options
Patients are increasingly leaning towards non-invasive methods due to their shorter recovery times and lower risks compared to surgical procedures. Intragastric balloons provide a minimally invasive way to achieve weight loss, making them appealing for those hesitant about surgery.
Advancements in Technology
Innovations in the design and materials of intragastric balloons are improving their safety and effectiveness. Notably, the introduction of swallowable gastric balloon capsules offers patients more flexible options for managing their weight.
Recent Market Developments
There have been significant advancements in the intragastric balloons market recently:
Regulatory Approvals
In October 2023, Spatz Medical received FDA approval for the Spatz3 Gastric Balloon, an innovative adjustable gastric balloon system. This approval underscores the ongoing innovation and regulatory progress in the market, allowing patients access to more advanced weight-loss solutions.
Launch of Innovative Products
Allurion Technologies has launched the Elipse Balloon in Brazil, recognized as the only intragastric balloon that can be inserted without the need for surgical procedures or anesthesia. Such innovations are setting new benchmarks in the weight-loss management sector.
Market Segmentation Analysis
The intragastric balloons market can be divided into segments based on type, filling material, and end-user:
By Type
In 2023, the single intragastric balloon segment accounted for the largest revenue share. This preference stems from their simplicity and lower risk of complications compared to double or triple balloon systems, making them a favored choice among patients and healthcare providers alike.
By Filling Material
Saline-filled intragastric balloons lead the market due to their superior adjustability and enhanced safety profile. These features make saline-filled options more desirable than gas-filled alternatives, effectively catering to individual patient needs.
By End-User
Hospitals dominate the intragastric balloons market, as they provide the necessary infrastructure and healthcare expertise for these procedures. Their comprehensive pre- and post-procedural care ensures optimal outcomes for patients opting for intragastric balloon placements.
Regional Insights
North America currently holds the leading position in the market, supported by advanced healthcare systems and a high prevalence of obesity. Meanwhile, the Asia-Pacific region is rapidly increasing its use of intragastric balloons, driven by growing awareness of obesity and healthcare investments. As lifestyles in this region increasingly adopt Western traits, the demand for this weight management method is expected to continue rising.
Key Market Players
Prominent players in the global intragastric balloons market include:
- Obalon Therapeutics
- Apollo Endosurgery Inc.
- Allurion Technologies Inc.
- Spatz Medical
- ReShape Lifesciences
- Lexel Medical
- Endalis
- MEDSIL
- Silimed
These companies are actively working to expand their market shares through product approvals, strategic launches, and partnerships, aiming to strengthen their competitive positions across various regions.
About Allied Market Research
Allied Market Research (AMR) specializes in delivering market research and business consulting services. The firm is dedicated to providing high-quality insights that facilitate strategic decision-making for clients across a wide range of industry sectors. With a commitment to accuracy and rigorous research methodologies, AMR ensures reliable data that supports business growth initiatives.
Contact Information
David Correa
1209 Orange Street, Corporate Trust Center, Wilmington, Delaware 19801, USA.
Toll-Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Email: help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Frequently Asked Questions
What is the projected growth rate of the intragastric balloons market?
The intragastric balloons market is projected to grow at a CAGR of 13.6% from 2024 to 2033.
What factors are driving the demand for intragastric balloons?
The main factors include rising obesity rates, the demand for non-surgical options, and increased patient awareness.
Which segment dominates the intragastric balloons market?
The single intragastric balloon segment has dominated the market due to its simplicity and reduced risk of complications.
What is the key advantage of saline-filled balloons over gas-filled?
Saline-filled balloons provide more adjustability and pose a lower risk of deflation and migration, enhancing their safety and efficacy.
Where are intragastric balloons most commonly used?
Hospitals are the primary facilities utilizing intragastric balloons, offering comprehensive care and advanced medical support.
